Engineered T Cell with CARs and TCRs for Hematologic Malignancy ASTCT 34:53 11 years ago 6 347 Скачать Далее
Engineering T Cells for Cancer - Carl June The Qualcomm Institute 48:50 6 years ago 4 543 Скачать Далее
Six-month follow up of CTL019 for diffuse large B-cell lymphoma ecancer 5:07 6 years ago 74 Скачать Далее
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients VJHemOnc – Video Journal of Hematology & HemOnc 2:10 7 years ago 598 Скачать Далее
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma ecancer 10:23 6 years ago 60 Скачать Далее
Keynote - Cancer Immunology (Carl H. June) Icahn School of Medicine 58:32 6 years ago 3 425 Скачать Далее
ASH2014: Stephan A. Grupp - CAR targeting CTL019 in Children with Relapsed, Refractory ALL Oncoletter 6:38 9 years ago 198 Скачать Далее
2022 Research Briefings: Carl June, University of Pennsylvania Perelman School of Medicine National Academy of Sciences 18:14 2 years ago 1 217 Скачать Далее
Prof. Gilles Salles: Interim analysis of the JULIET study of CTL019 in R/R DLBCL Lymphoma Hub 4:41 7 years ago 265 Скачать Далее
Michael Milone - Immunotherapy of Cancer Using Genetically Enhanced T Cells Labroots 54:35 7 years ago 272 Скачать Далее
Prof. Stephen J. Schuster, M.D.: CTL019 in R/R DLBCL – interim results interview from ICML 2017 Lymphoma Hub 17:10 7 years ago 1 314 Скачать Далее
Key novel agents for relapsed diffuse large B-cell lymphoma HMP Education 22:26 6 years ago 1 250 Скачать Далее
T Cell Therapy for Acute Lymphoblastic Leukemia: Results as of November 2013 The Children's Hospital of Philadelphia 8:32 10 years ago 19 469 Скачать Далее
